Renew News2020-10-16T12:23:06-07:00

U.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis

October 16th, 2020|

SAN DIEGO--(BUSINESS WIRE)--Renew Biopharma today announced that the United States Patent and Trademark Office (USPTO) has granted powerful patent claims on the landmark patent application (WO2019183152) relating to the rational-based engineering of a key enzyme that is most efficient for large-scale microbial cannabinoid biosynthesis (i.e. NphB). 

Next Gen Cannabinoids for Clinical Neurology

Contact Us

General Inquiries: info@renewbiopharma.com

Press Inquiries: press@renewbiopharma.com

Contact Us